2002 (v1)
Publication
No description
Uploaded on: May 13, 2023
No description
The combination of Epirubicin and Taxotere (ET), both drugs given at 75 mg/ m2day 1q. 21 days, is widely used in the treatment of advanced breast cancer. We previously reported a phase I study which indicated that Capecitabine 2000 mg/m2/day for 14 consecutive days could be safely combined with full doses of ET. Among 23 patients treated 21...